סינגפור - אנגלית - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - tacrolimus - capsule, extended release - tacrolimus 1.000 mg

סינגפור - אנגלית - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - tacrolimus - capsule, extended release - tacrolimus 5.000 mg

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

accord healthcare limited - tacrolimus - capsules hard - 0.5 milligram

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

accord healthcare limited - tacrolimus - capsules hard - 1 milligram

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

accord healthcare limited - tacrolimus monohydrate - capsules hard - 5 milligram

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sirolimus -

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - mycophenolate mofetil 250mg;   - capsule - 250 mg - active: mycophenolate mofetil 250mg   excipient: croscarmellose sodium gelatin   hyprolose indigo carmine iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose povidone purified talc sodium laurilsulfate   tekprint black sw-9008 titanium dioxide   water   - myaccord is indicated for the prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - mycophenolate mofetil 500mg;   - film coated tablet - 500 mg - active: mycophenolate mofetil 500mg   excipient: croscarmellose sodium hyprolose magnesium stearate microcrystalline cellulose opadry purple 03b50110 povidone purified talc - for the prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 0.51mg;  ; sirolimus 0.5mg - coated tablet - 0.5 mg - active: sirolimus 0.51mg   excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate ferrous oxide glyceryl mono-oleate iron oxide yellow lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac titanium dioxide active: sirolimus 0.5mg excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate ferrous oxide glyceryl mono-oleate iron oxide yellow lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac sucrose titanium dioxide - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 1mg;  ; sirolimus 1mg - coated tablet - 1 mg - active: sirolimus 1mg   excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate glyceryl mono-oleate lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac sucrose titanium dioxide active: sirolimus 1mg excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate glyceryl mono-oleate lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac sucrose titanium dioxide - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.